Bronchogen
Peptide therapy: benefits, side effects, cost and protocols
C18H30N4O9
Bronchogen (Ala-Glu-Asp) is a short bioregulatory peptide targeting bronchial and lung tissue. Part of the Khavinson bioregulator peptide series, it is studied for its potential to normalize respiratory tract function and support lung health.
Sources: FDA / PubMed / ClinicalTrials.gov View
Spec sheet
- FDA status
- Research Only Not currently approved for human use in the US. Available as a research compound. Not eligible for compounding.
- Evidence
- Emerging Evidence
Who it's for
Who Bronchogen is usually considered for
- Bronchial tissue support
- 4 preclinical studies
- Respiratory function
- 2 preclinical studies
- Mucosal health
- Age-related lung support
- 3 preclinical studies
- Primarily animal or early-phase data
Mechanism
How Bronchogen works
Short bioregulator peptide that interacts with DNA promoter regions in bronchial epithelial cells, potentially modulating gene expression related to mucosal defense and tissue repair.
Evidence
Key studies
12 papers on PubMed / 7 human trials
- 01
[ANTIINFLAMMATORY AND REGENERATIVE EFFECT OF PEPTIDE THERAPY IN THE MODEL OF OBSTRUCTIVE LUNG PATHOLOGY]
- 02
Titova ON, Kuzubova NA, Lebedeva ES et al
Ross Fiziol Zh Im I M Sechenova / Ross Fiziol Zh Im I M Sechenova / Animal
- 03
Bronchogen peptide reduced lung inflammation and restored bronchial epithelium structure in COPD model
- 04
Modulating Effect of Peptide Therapy on the Morphofunctional State of Bronchial Epithelium in Rats with Obstructive Lung Pathology
- 05
Kuzubova NA, Lebedeva ES, Dvorakovskaya IV et al
Bull Exp Biol Med / Bull Exp Biol Med / Animal
- 06
Tetrapeptide Bronchogen restored bronchial epithelium structure and reduced inflammation in COPD rats
- 07
Short Exogenous Peptides Regulate Expression of CLE, KNOX1, and GRF Family Genes in Nicotiana tabacum
- 08
Fedoreyeva LI, Dilovarova TA, Ashapkin VV et al
In Vitro / Biochemistry (Mosc)
- 09
Exogenous peptides regulate growth and differentiation genes in tobacco callus cultures
- 10
Peptides tissue-specifically stimulate cell differentiation during their aging
Compound
Bronchogen compound data
- Formula
- C18H30N4O9
- Mol. weight
- 446.5 g/mol
- PubChem CID
- 11690869 ↗
- IUPAC
- (2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-aminopropanoyl]amino]-4-carboxy-butanoyl]amino]-3-carboxy-propanoyl]amino]-4-methyl-pentanoic acid
FAQ
Bronchogen questions
What is BRONCHOGEN?
Bronchogen is a Khavinson bioregulator tripeptide (Ala-Glu-Asp) researched for bronchial and respiratory tissue support, particularly in age-related respiratory decline.
How does BRONCHOGEN work?
Short bioregulator peptide that interacts with DNA promoter regions in bronchial epithelial cells, potentially modulating gene expression related to mucosal defense and tissue repair.
Is BRONCHOGEN legal to buy?
BRONCHOGEN is sold as a research chemical for laboratory use only. It is not approved for human use by the FDA. Regulations vary by jurisdiction.
Where can I buy BRONCHOGEN?
BRONCHOGEN is available as a research compound from verified online vendors. Always verify third-party testing before purchasing.
What category does BRONCHOGEN belong to?
BRONCHOGEN is primarily classified as a tissue repair & healing peptide. Peptides studied for their potential in wound healing, tendon/ligament repair, gut healing, and general tissue regeneration.
What are the research benefits of BRONCHOGEN?
BRONCHOGEN has been studied for: Bronchial tissue support, Respiratory function, Mucosal health, Age-related lung support. Khavinson bioregulator; respiratory/bronchial tissue focus.
News
Bronchogen in the news
Investigating the Broader Research Potential of Bronchogen Across Complex Biological Systems - Capital Press
Capital Press / 19 days ago
Bronchogen Peptide: An Exploration of Possible Properties and Functions - News9live
News9live / 29 months ago
News aggregated via Google News. Inclusion does not imply endorsement.
Considering Bronchogen?
The 2-minute quiz matches you with licensed providers who offer it. A clinician decides if it fits.